TransPerfect Simplifies CRA Site Visits with myTI

NEW YORK, NY, May 10, 2019 – TransPerfect Life Sciences, a leading provider of services and technologies to support global product development for the life sciences industry, has released version 1.2 of myTI, the mobile application that enables real-time eTMF management and oversight for study teams on the go. This new release of the mobile version of the Trial Interactive e-clinical platform simplifies CRA site visits, providing even more ways to speed timelines and reduce risk.

Simplifying site visits and mobile reconciliation is a key aim of myTI 1.2. The app allows CRAs to perform and record required site visit tasks directly from a mobile device and features enhanced TMF review and documentation capabilities, eliminating paper documentation, and time-consuming manual review.

CRAs who use myTI 1.2 will benefit from enhancements that include:

• Reconciliation Tasks – Complete reconciliation more quickly with instant access to site files
• Site Visit Reporting – Improve oversight and overall TMF management with live reporting
• Documentation Access – Remove barriers for CRA handovers, co-monitoring, and training by accessing documents submitted by any author
• Query Visibility and Action – Promote proactive TMF management with a complete query view that makes it easy to review and respond to queries. Additionally, email notifications link directly to tasks in myTI to encourage immediate action
• E-Signature Document Approval – Speed document approval with the convenience of e-signature
• Rejected Documents View – Improve TMF completeness with a real-time rejected documents view
• Enhanced Support – Access support resources at any time with an online help manual and in-app contact capabilities for live Trial Interactive support
• SSO – Eliminate password and login headaches with single sign-on access to myTI

TransPerfect President and CEO Phil Shawe stated, “Any technology that simplifies essential site visit tasks is a significant advancement for those performing global clinical trials. I’d like to thank our CRA and clinical stakeholder consultants, who were instrumental in shaping this version of our Trial Interactive mobile application.”

About Trial Interactive

TransPerfect’s Trial Interactive is an industry leader in practical e-clinical innovation that simplifies and automates clinical processes for sponsors, CROs, and sites around the world. The 21 CFR Part 11 compliant unified platform delivers an author-to-archive collaboration experience with solutions for clinical document management, site selection, site activation, e-learning, compliance training, quality, and more with seamless solution interoperability and indexing to the eTMF. Trial Interactive is consistently selected by clinical professionals for providing the most comprehensive yet intuitive experience with the most complete offering of technology and expert TMF services. Trial Interactive helps study teams streamline their operations by cutting unnecessary expenses, expediting timelines, reducing compliance risks, and improving operational excellence. For more information on Trial Interactive, please contact info@trialinteractive.com or +1 212.400.8848, or visit www.trialinteractive.com.

About TransPerfect

TransPerfect is the world’s largest provider of language and technology solutions for global business. From offices in over 100 cities on six continents, TransPerfect offers a full range of services in 170+ languages to clients worldwide. More than 5,000 global organizations employ TransPerfect’s GlobalLink® Product Suite to simplify management of multilingual content. With an unparalleled commitment to quality and client service, TransPerfect is fully ISO 9001 and ISO 17100 certified. TransPerfect has global headquarters in New York, with regional headquarters in London and Hong Kong. For more information, please visit our website at www.transperfect.com.